1.Contribution of Borneolum syntheticum to the Intervention Effect of Liuwei Dihuang Pill () on Experimental Retinal Degeneration.
Li-Na LIANG ; Yu-Yang BAI ; You-Zhi TANG ; Qiang CHEN ; Xue-Li LI ; Qun-Ying MA ; Jie LIANG ; Jiao LI
Chinese journal of integrative medicine 2018;24(6):442-447
OBJECTIVETo observe the contribution of Borneolum syntheticum to the intervention effect of Liuwei Dihuang Pill (, LDP) on experimental retinal degeneration, and initially investigate the mechanism of Borneolum syntheticum as meridian-lead-in drug.
METHODSA total of 180 sodium iodateinduced retinital degeneration rats were randomly divided into three groups, including distilled water group, LDP group, and LDP+Borneolum syntheticum (LDP+BS) group. Twenty normal rats were fed regularly without any treatment as normal control. On day 7 and 14 after treatment, histopathological study and transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL) test were performed to evaluate the retinopathy. Claudin-5 expression at blood-retina barrier (BRB) was detected by Western blot at different time points from 0.5 to 8 h after gavage.
RESULTSOn day 7 and 14 after treatment, the retinal lesion grades were significantly different among the three groups (P<0.05). The grade in the LDP+BS group was significantly less than the LDP and distilled water groups (both P<0.05), no significant difference was observed between the LDP and distilled water groups (P>0.05). The apoptosis rates in the LDP+BS group was significantly less than the distilled water and LDP groups (both P<0.05), while there was no significant difference between LDP and distilled water groups (P>0.05). Expression of claudin-5 in LDP+BS group was significantly less than the other two groups at 0.5, 1 and 2 h after gavage (P<0.05). There was no apparent difference among the three groups at 4 and 8 h after gavage (P>0.05).
CONCLUSIONBorneolum syntheticum could strengthen the effect of LDP on experimental retinal degeneration, indicated that Borneolum syntheticum might play the role of meridian-lead-in drug in the formula. The mechanism may be due to Borneolum syntheticum could promote the physiologically openness of bloodretina barrier through transiently affecting the expression of claudin-5.
Animals ; Apoptosis ; drug effects ; Claudin-5 ; metabolism ; Disease Models, Animal ; Drugs, Chinese Herbal ; pharmacology ; therapeutic use ; Rats, Sprague-Dawley ; Retinal Degeneration ; chemically induced ; drug therapy ; pathology ; Retinal Pigment Epithelium ; drug effects ; pathology ; Time Factors
2.Delay of Photoreceptor Cell Degeneration in rd Mice by Systemically Administered Phenyl-N-tert-butylnitrone.
Jin Hyoung KIM ; Jeong Hun KIM ; Young Suk YU ; Seon Mi JEONG ; Kyu Won KIM
Korean Journal of Ophthalmology 2005;19(4):288-292
PURPOSE: To study the effect of systemic administration of phenyl-N-tert-butylnitrone (PBN) on the degeneration of photoreceptor cells in rd mice. METHODS: PBN was injected intraperitoneally into FVB/rd mice on postnatal days (P) 5 to 14 (group A), and P10 to 18 (group B). At days P14, 16, 18, 20 and 27, morphological changes and apoptosis were analyzed by staining with hematoxylin and eosin or DAPI. The effect of PBN on apoptosis was analyzed in retinal pigment epithelial (RPE) cells by the measurement of caspase-3 activity. RESULTS: In control and group B mice, the outer nuclear layer (ONL) of the retina was composed of 8-10 rows at P12, and rapidly decreased to one row at P18. In group A mice, the ONL was preserved with 5-7 rows at P18, and decreased to one row at P22. PBN inhibited caspase-3 activity in cultured RPE cells. CONCLUSIONS: PBN delayed, but did not block, the degeneration of photoreceptor cells in rd mice. PBN may exert its inhibitory effect during the early phase of photoreceptor cell degeneration.
Retinal Degeneration/*drug therapy/metabolism/pathology
;
Pigment Epithelium of Eye/drug effects/metabolism/pathology
;
Photoreceptors, Vertebrate/drug effects/metabolism/*pathology
;
Nitrogen Oxides/*administration & dosage/pharmacokinetics/therapeutic use
;
Neuroprotective Agents/*administration & dosage/pharmacokinetics/therapeutic use
;
Mice
;
Male
;
Injections, Intraperitoneal
;
Free Radical Scavengers/*administration & dosage/pharmacokinetics/therapeutic use
;
Follow-Up Studies
;
Female
;
Enzyme Precursors/metabolism
;
Disease Models, Animal
;
Cells, Cultured
;
Caspases/metabolism
;
Caspase 3
;
Apoptosis/drug effects
;
Animals